Early life aflatoxin B1 exposure and epigenetic programming in Nigerian Newborns

尼日利亚新生儿生命早期黄曲霉毒素 B1 暴露和表观遗传编程

• 批准号: 10518414
• 负责人: Oluwakemi Anuoluwapo Rotimi
• 金额: $ 8.16万
• 依托单位: COVENANT UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-09-21 至 2027-06-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10518414
• 关键词: Adolescence; Aflatoxin B1; Aflatoxins; Africa; Africa South of the Sahara; African; Animal Feed; Area; Aspergillus; Binding; Biological Products; Birth; Blood; Blood specimen; Breast Feeding; Cancer Etiology; Carcinogens; Chemical Agents; Child; Cohort Studies; Country; Cytochrome P450; DNA; DNA Methylation; Data; Development; Diagnosis; Disease; Disease susceptibility; Environment; Environmental Exposure; Environmental Pollution; Enzymes; Epigenetic Process; Exposure to; First Pregnancy Trimester; Food; Food Contamination; Gene Expression; Gene Expression Profiling; Goals; Grain; Hepatotoxicity; Heritability; High Pressure Liquid Chromatography; Hospitals; Human; Incidence; Life; Link; Liver; Lysine; Malignant Neoplasms; Malignant neoplasm of liver; Membrane; Methylation; Modification; Molds; Molecular; Mothers; Mutation; Newborn Infant; Nigeria; Nigerian; Nucleic Acids; Nutrient; Onset of illness; Organ; Placenta; Plasma; Play; Poison; Polymerase Chain Reaction; Population; Predisposition; Pregnancy; Pregnant Women; Primary carcinoma of the liver cells; Process; Public Health; RNA; Regulation; Research; Research Personnel; Risk; Rodent; Role; Route; Rural; Testing; Third Pregnancy Trimester; Time; Toxic Environmental Substances; Tumor Suppressor Genes; Umbilical Cord Blood; Weaning; Woman; adduct; bisulfite; carcinogenesis; cohort; early childhood; early experience; early life exposure; early onset; epigenetic marker; epigenome; in utero; infancy; insight; liver development; prenatal exposure; pyrosequencing; recruit; urban area

Project Summary Aflatoxin B1 (AFB1) is a major cause of hepatocellular carcinoma (HCC) in Sub Saharan Africa, where aflatoxin contamination is common. In these areas, exposure to AFB1 starts early in life through maternal routes during pregnancy. Populations in these countries experience early onset of HCC, and in utero AFB1 exposure may be a contributing factor to the onset of the disease. Exposures to nutrients, toxic chemicals and biological agents during gestation and early childhood play a critical role in determining susceptibility to diseases later in life. The mechanism of early onset of carcinogenesis may include epigenetic changes in tumor suppressor genes (TSGs). Our previous rodent study showed that in utero AFB1 exposure can alter DNA methylation of TSGs. It is necessary to investigate the impact of in utero AFB1 exposure on methylation and expression of TSGs in humans. The overall hypothesis is that in utero AFB1 exposure will differentially methylate TSGs, and this methylation will inversely correlate with the expression of the TSGs. The overall objective of this project is to establish a pre-birth cohort and study the association between in utero exposure to AFB1 and DNA methylation changes in TSGs of newborns in Nigeria. To achieve this, we will recruit pregnant women in the first trimester from two Nigerian hospitals serving a rural and an urban area. We hypothesize that Nigerian women will have a range of AFB1 exposure levels detectable in plasma. We hypothesize that in utero AFB1 exposure will be associated with differential methylation and expression of TSGs in cord blood samples. The specific aims of this project are to 1) determine the levels of AFB1 in the plasma of pregnant women, using HPLC, collected during the first and third trimesters of pregnancy, and newborns (cord blood), 2) assess the DNA methylation of TSGs in the cord blood via pyrosequencing and to determine if AFB1 concentration is associated with the levels of DNA methylation, 3) determine the expression of TSGs in the cord blood using real-time quantitative PCR and determine if gene expression is inversely correlated with methylation changes in the TSGs. The findings of this study will provide data on AFB1 exposure among pregnant women in Nigeria and its subsequent effect on the epigenome of newborns. This data will provide direction for future research developing epigenetic biomarkers of AFB1 exposure as well as investigating epigenetic mechanisms associated with prenatal exposure to AFB1 and the risk of developing liver cancer in Africa. This research direction may provide insight into reducing the incidence of this cancer in sub-Saharan Africa, especially in countries such as Nigeria, where AFB1 exposure is highly prevalent. Through this research, the PI will become a leader in environmental epigenetics, studying how early-life exposure to environmental contaminants of Public Health concerns in Africa contributes to the development of non- communicable diseases later in life.

项目摘要 黄曲霉毒素B1（AFB1）是撒哈拉以南非洲的肝细胞癌（HCC）的主要原因 黄曲霉毒素污染很常见。在这些领域，暴露于AFB1的早期开始通过母体开始 怀孕期间的路线。这些国家的人口经历了肝癌和子宫AFB1的早期发作 暴露可能是导致疾病发作的一个因素。暴露于营养素，有毒化学物质和 妊娠和幼儿期间的生物剂在确定易感性方面起着至关重要的作用 以后的疾病。癌变早期发作的机制可能包括表观遗传变化 肿瘤抑制基因（TSG）。我们以前的啮齿动物研究表明，在子宫内afb1暴露会改变 TSG的DNA甲基化。有必要研究子宫AFB1暴露对甲基化的影响 和TSG在人类中的表达。总体假设是，在子宫里，AFB1暴露会有所不同 甲基盐TSG，这种甲基化将与TSG的表达成反比。总体 该项目的目的是建立出生前队列，并研究子宫内的关联 尼日利亚新生儿TSG的AFB1和DNA甲基化变化。为了实现这一目标，我们将招募 孕妇在三个尼日利亚医院的孕妇为乡村和一个城市地区服务。我们 假设尼日利亚妇女将在血浆中检测到一系列AFB1暴露水平。我们 假设在子宫中，AFB1暴露将与差异甲基化和表达有关 脐带血样品中的TSG。该项目的具体目的是1）确定AFB1的水平 使用HPLC的孕妇血浆，在怀孕的第一和第三个三物种中收集 新生儿（脐带血），2）通过焦磷酸测序评估脐带血中TSG的DNA甲基化 确定AFB1浓度是否与DNA甲基化水平相关，3）确定表达 使用实时定量PCR，脐带血中的TSG的of，并确定基因表达是否反相 与TSG的甲基化变化相关。这项研究的发现将提供有关AFB1的数据 尼日利亚孕妇的暴露及其对新生儿表观基因组的影响。这 数据将为未来的研究提供指导，开发AFB1暴露的表观遗传生物标志物以及 调查与产前暴露于AFB1相关的表观遗传机制和发展的风险 非洲的肝癌。这个研究方向可能会洞悉降低该癌症的发生率 撒哈拉以南非洲，特别是在尼日利亚等国家，那里的AFB1暴露高度普遍。通过 这项研究，PI将成为环境表观遗传学的领导者 非洲公共卫生问题的环境污染物有助于发展非洲 以后生活中的传染病。